Activated apoptotic and anti-survival effects on rat hearts with fructose induced metabolic syndrome

Cell Biochemistry and Function

Volumn 32, Issue 2, 2014, Pages 133-141

  Cheng, Shiu Min ^a   Cheng, Yu Jung ^b   Wu, Liang Yi ^c   Kuo, Chia Hua ^b,d   Lee, Yi Shin ^b   Wu, Ming Che ^e   Huang, Chih Yang ^a,b,f   Ting, Hua ^e,g   Lee, Shin Da ^a,b,h  

^a ASIA UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^d UNIVERSITY OF TAIPEI   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

^g CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^h SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Apoptosis; Fas receptor; Fructose; Heart; Metabolic syndrome; TNF alpha

Indexed keywords

CASPASE 3; CASPASE 8; CHOLESTEROL; CYTOCHROME C; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; FAS RECEPTOR; FRUCTOSE; GLUCOSE; INSULIN; MITOCHONDRIAL PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; RECEPTOR; SOMATOMEDIN; SOMATOMEDIN RECEPTOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; CARBOHYDRATE DIET;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ARTIFICIAL DIET; BLOOD PRESSURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOARCHITECTURE; ELEVATED BLOOD PRESSURE; FRUCTOSE INDUCED METABOLIC SYNDROME; HEART MUSCLE CELL; HISTOPATHOLOGY; ISOLATED HEART; MALE; METABOLIC SYNDROME X; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CARBOHYDRATE DIET; DRUG EFFECTS; HEART MUSCLE; METABOLISM; MITOCHONDRION; PATHOLOGY; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; APOPTOSIS; CELL SURVIVAL; DIETARY CARBOHYDRATES; FRUCTOSE; MALE; METABOLIC SYNDROME X; MITOCHONDRIA; MYOCARDIUM; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84895523296     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2982     Document Type: Article

References (36)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
2. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
3. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010; 56: 1113-1132.
4. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245-1250.
5. Nisoli E, Clementi E, Carruba MO, Moncada S. Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ Res 2007; 100: 795-806.
6. Narula J, Pandey P, Arbustini E, et al. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA 1999; 96: 8144-8149.
7. Boudina S, Abel ED. Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. Physiology (Bethesda) 2006; 21: 250-258.
8. Cheng SM, Ho TJ, Yang AL, et al. Exercise training enhances cardiac IGFI-R/PI3K/Akt and Bcl-2 family associated pro-survival pathways in streptozotocin-induced diabetic rats. Int J Cardiol 2012. doi:10.1016/j.ijcard.2012.01.031.
9. Lee SD, Shyu WC, Cheng IS, et al. Effects of exercise training on cardiac apoptosis in obese rats. Nutr Metab Cardiovasc Dis 2012. doi:10.1016/j.numecd.2011.11.002.
10. Huang CY, Yang AL, Lin YM, et al. Anti-apoptotic and pro-survival effects of exercise training on hypertensive hearts. J Appl Physiol 2012; 112: 883-891.
11. Lee SD, Chu CH, Huang EJ, et al. Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation. Am J Physiol Endocrinol Metab 2006; 291: E306-E314.
12. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 1998; 82: 1111-1129.
13. Bishopric NH, Andreka P, Slepak T, Webster KA. Molecular mechanisms of apoptosis in the cardiac myocyte. Curr Opin Pharmacol 2001; 1: 141-150.
14. Barnhart BC, Alappat EC, Peter ME. The CD95 type I/type II model. Semin Immunol 2003; 15: 185-193.
15. Bang S, Jeong EJ, Kim IK, Jung YK, Kim KS. Fas- and tumor necrosis factor-mediated apoptosis uses the same binding surface of FADD to trigger signal transduction. A typical model for convergent signal transduction. J Biol Chem 2000; 275: 36217-36222.
16. Jeremias I, Stahnke K, Debatin KM. CD95/Apo-1/Fas: independent cell death induced by doxorubicin in normal cultured cardiomyocytes. Cancer Immunol Immunother 2005; 54: 655-662.
17. Adams JM, Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 2001; 26: 61-66.
18. Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc Natl Acad Sci USA 2002; 99: 12825-12830.
19. Brown GC, Borutaite V. Nitric oxide, cytochrome c and mitochondria. Biochem Soc Symp 1999; 66: 17-25.
20. Lee SD, Kuo WW, Lin JA, et al. Effects of long-term intermittent hypoxia on mitochondrial and Fas death receptor dependent apoptotic pathways in rat hearts. Int J Cardiol 2007; 116: 348-356.
21. Lee SD, Kuo WW, Wu CH, et al. Effects of short- and long-term hypobaric hypoxia on Bcl2 family in rat heart. Int J Cardiol 2006; 108: 376-384.
22. Lee SD, Kuo WW, Lin JA, et al. Effects of long-term intermittent hypoxia on mitochondrial and Fas death receptor dependent apoptotic pathways in rat hearts. Int J Cardiol 2007; 116: 348-356.
23. Lee SD, Tzang BS, Kuo WW, et al. Cardiac fas receptor-dependent apoptotic pathway in obese Zucker rats. Obesity (Silver Spring) 2007; 15: 2407-2415.
24. Lu MC, Tzang BS, Kuo WW, et al. More activated cardiac mitochondrial-dependent apoptotic pathway in obese Zucker rats. Obesity Silver Spring, Md 2007; 15: 2634-2642.
25. Sun HY, Zhao RR, Zhi JM. Insulin-like growth factor I inhibits cardiomyocyte apoptosis and the underlying signal transduction pathways. Methods Find Exp Clin Pharmacol 2000; 22: 601-607.
26. Hong F, Kwon SJ, Jhun BS, et al. Insulin-like growth factor-1 protects H9c2 cardiac myoblasts from oxidative stress-induced apoptosis via phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways. Life Sci 2001; 68: 1095-1105.
27. Ren J, Samson WK, Sowers JR. Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol 1999; 31: 2049-2061.
28. Vincent AM, Feldman EL. Control of cell survival by IGF signaling pathways. Growth Horm IGF Res 2002; 12: 193-197.
29. Matsui T, Davidoff AJ. Assessment of PI-3 kinase and Akt in ischemic heart diseases in diabetes. Methods Mol Med 2007; 139: 329-338.
30. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996; 86: 147-157.
31. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987; 10: 512-516.
32. Rutledge AC, Adeli K. Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr Rev 2007; 65: S13-S23.
33. Tappy L, Le KA TC, Paquot N. Fructose and metabolic diseases: new findings, new questions. Nutrition Burbank, Los Angeles County, Calif 2010; 26: 1044-1049.
34. Ren J, Pulakat L, Whaley-Connell A, Sowers JR. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med (Berlin, Germany) 2010; 88: 993-1001.
35. Kuo WW, Chung LC, Liu CT, et al. Effects of insulin replacement on cardiac apoptotic and survival pathways in streptozotocin-induced diabetic rats. Cell Biochem Funct 2009; 27: 479-487.
36. McGowan BS, Ciccimaro EF, Chan TO, Feldman AM. The balance between pro-apoptotic and anti-apoptotic pathways in the failing myocardium. Cardiovasc Toxicol 2003; 3: 191-206.